Quality in Primary Care Open Access

  • ISSN: 1479-1064
  • Journal h-index: 27
  • Journal CiteScore: 6.64
  • Journal Impact Factor: 4.22
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Mohs Micrographic Surgery: Why is the gold standard for non-melanoma skin cancers?

Joint Event on 29th International Conference on Pediatrics & Primary Care & 15th International Conference on Clinical Dermatology
September 23-24, 2019 Barcelona, Spain

Hossein Yavari

University of Miami, USA

Scientific Tracks Abstracts: Qual Prim Care


The new and dramatic findings on the treatment of life-threatening skin cancers like high stage melanoma, such as targeted therapies and immunotherapies, have changed the physicians’ approach and peoples’ life over past several years. Fortunately, melanoma is not the most common skin cancer while non-melanoma skin cancers, basal cell and squamous cell carcinoma as most common skin cancers are in rise. Now, Mohs surgery is the gold standard for successfully treating many types of basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), specially the ones are located in critical areas of skin like periorbital, nasal, perioral and lips, auricular, scalp, genital, toes and fingers. If a type of BCC or SCC is big, growing aggressively and becoming a large lesion, has indistinct border or recurred after a previous surgery, Mohs would be the gold standard. The most important reason why Mohs is becoming the gold standard for BCC and SCC is because of low recurrence rate which is usually less than 6 percent for SCC and less than 1 percent for BCC. This a great news for all people with these common skin cancers. The second reason is that in Mohs we can save the highest part of normal tissue without damaging the surroundings while in traditional excisions either we leave a part of cancer behind or we remove a part of healthy tissue that leads to functionally and cosmetically undesirable results. Cure rates for Mohs is above 98 percent if the lesion is primary, and around 95 percent for recurrent lesions removed incompletely by traditional surgeries. In Mohs surgery the histopathology investigation is done right after removal and while patient still is in the clinic for further steps. Combination of high cure rate, less damage to normal skin and better cosmetic and functional result, brings the Mohs on top of all old surgical procedure and the first line treatment for many types of non-melanoma skin cancers across the world.

Recent Publications

1. Clinical characteristics of progressive vitiligo, Iranian Journal of Dermatology, Vol. 10, No. 40, 2007

2. Scleredema Adultorum Of Buschke, A Case with Multiple Causes, The Internet Journal of Dermatology, Volume 4 Number 2

3. Real life management of chronic urticaria, Dermatol Ther. 2018 Dec 5:e12796. doi: 10.1111/dth.12796

Biography :

Hossein Yavari, MD is specialist in Dermatology and Hair Transplantation Surgery. He is the fellowship of Cutaneous and Mohs surgery from University of Miami, Florida, USA. He is the Diplomate of American Board of Hair Restoration Surgery. He has over fifteen years’ experience in both Clinical and Cosmetic Dermatology in Dubai and Los Angeles, California, USA. He is the member of American Academy of Dermatology, International Society of Hair Restoration Surgery and the Correspondent Fellow of American Society for Dermatologic Surgery. He has the background of Assistant Professor of Dermatology and the Head of Dermatology Department and currently practices in Dubai and USA.

E-mail: drhyavari@gmail.com